Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post S&P 500 Rises from Bearish to Neutral, But Will It Last? April 28, 2025 Related Posts John Ciampaglia: Gold’s “Extreme” Run — Price Drivers and What’s Next April 29, 2025 What is the VIX Index? April 29, 2025 4 Biggest Cybersecurity ETFs in 2025 April 29, 2025